News

Synthon v Teva [2017] EWCA Civ 14822 May 2017Andrew Lykiardopoulos QC represented the Appellant, Synthon, in its appeal concerning Teva’s patent for glatiramer acetate (marketed as “Copaxone”). The Patent related to a method of making glatiramer acetate with limited levels bromine and free metal impurities. Synthon had challenged the validity of the patent on grounds of lack of novelty, obviousness and insufficiency. At […]
Varian Medical Systems International AG v Elekta [2017] EWHC 712 (Pat)18 May 2017James Abrahams QC and James Whyte successfully represented the Defendants (Elekta) in Varian’s claim for infringement of its patent for a combined MRI and radiotherapy device. Elekta denied that its combined MRI and radiotherapy machine infringed the Patent, and further claimed that the Patent was invalid for insufficiency, obviousness and added matter. The judge held […]
Teva UK Ltd v Merck Sharp & Dohme Corp [2017] EWHC 539 (Pat)17 May 2017Charlotte May QC and Lindsay Lane represented the first claimant (“Teva”) in its successful challenge of the defendant’s (“Merck”) supplementary protection certificate (SPC) for an anti-viral drug marketed as Atripla.   The SPC covered a combination of the active ingredient efavirenz together with emtricitabine and tenofovir. The Court agreed with Teva’s case that the SPC […]
Wellbeing at the Bar17 May 2017Charlotte May QC was part of a panel of experts speaking at the Wellbeing Evening hosted by the Bar Representation Committee at Lincoln’s Inn on 8 May 2017. The panel discussion included advice about how to raise awareness of wellbeing issues and to use wellbeing resources to provide support in the workplace. The closing address […]
Glaxo Wellcome UK Ltd v Sandoz Ltd [2017] EWCA Civ 33510 May 2017This appeal is in a large scale action for Trade Mark infringement and passing off brought by Glaxo against Sandoz in relation to respiratory inhalers. The UK action forms part of a series of international disputes concerning these pharmaceutical products. Glaxo owns an EU colour per se trade mark which is visually represented by a […]
Glaxo Wellcome UK Ltd v. Sandoz Ltd [2017] EWCA Civ 33510 May 2017This appeal is in a large scale action for Trade Mark infringement and passing off brought by Glaxo against Sandoz in relation to respiratory inhalers. The UK action forms part of a series of international disputes concerning these pharmaceutical products. Glaxo owns an EU colour per se trade mark which is visually represented by a […]
Unwired Planet International Ltd v Huawei Technologies Co. Ltd [2017] EWHC 711 (Pat)4 May 2017Adrian Speck QC, Isabel Jamal and Tom Jones appeared for the Claimant, Unwired Planet, and Andrew Lykiardopoulos QC appeared for the Defendant, Huawei, in a landmark action concerning the nature of a patent holder’s obligations to license Standard Essential Patents (SEPs) on Fair, Reasonable and Non-Discriminatory (FRAND) terms.   In a much-anticipated judgment, Birss J […]
Charlotte May speaks at the launch of the London Chapter of ChIPs hosted at the Supreme Court S4 May 2017Charlotte May QC was one of the panellists at the launch of the London Chapter of ChIPs hosted at the Supreme Court on Thursday 27 April. ChIPs is a non-profit organisation dedicated to advancing women in technology, law and policy. The launch of the London Chapter represents an important step in helping to realise the […]
(1) Sandoz Ltd (2) Hexal AG v (1) G.D. Searle LLC (2) Janssen Sciences Ireland UC [2017] EWHC 987 (Pat)3 May 2017Charlotte May QC and William Duncan represented the claimants in an action concerning the defendants’ supplementary protection certificate (SPC) for the drug darunavir (marketed as “Prezista”). The case raised a question about the correct application of article 3(a) of Regulation 469/2009/EC (the “SPC Regulation”) – which states that a product the subject of an SPC […]
Charlotte May talks at the launch of the London Chapter of ChIPs hosted at the Supreme Court27 April 2017 Charlotte May QC was one of the panellists at the launch of the London Chapter of ChIPs hosted at the Supreme Court on Thursday 27 April. ChIPs is a non-profit organisation dedicated to advancing women in technology, law and policy. The launch of the London Chapter represents an important step in helping to realise the […]